Development of levofloxacin inhalation solution to treat in patients with cystic fibrosis

Development of levofloxacin inhalation solution to treat in patients with cystic fibrosis

Inhaled therapies allow for the targeted delivery of antimicrobials directly into the lungs and have been widely used in the treatment of cystic fibrosis (CF) acute pulmonary exacerbations. Nebulized levofloxacin solution (MP-376) is a novel therapy that is currently being evaluated in phase I, II,...

Full description

Bibliographic Details
Main Authors:	Chris Stockmann, Catherine M.T. Sherwin, Krow Ampofo, Michael G. Spigarelli
Format:	Article
Language:	English
Published:	SAGE Publishing 2014-02-01
Series:	Therapeutic Advances in Respiratory Disease
Online Access:	https://doi.org/10.1177/1753465813508445

Similar Items

Aztreonam Lysine Inhalation Solution in Cystic Fibrosis
by: Elizabeth Claire Elson, et al.
Published: (2019-04-01)

Pharmacotherapy of cystic fibrosis: inhaled antibiotics
by: N. I. Kapranov
Published: (2013-12-01)

Evidence for the efficacy of aztreonam for inhalation solution in the management of in patients with cystic fibrosis
by: Christine Hansen, et al.
Published: (2015-02-01)

Use of inhaled tobramycin in patients with cystic fibrosis
by: A G Chermensky, et al.
Published: (2010-08-01)

The effects of inhaled aztreonam on the cystic fibrosis lung microbiome
by: Alya A. Heirali, et al.
Published: (2017-05-01)

Enhancing adherence to inhaled therapies in cystic fibrosis
by: Paula Lomas
Published: (2014-04-01)

Drug schedule of inhaled medications in cystic fibrosis
by: Conerly, Megan Nicole
Published: (2009)

Nebulizer Care and Inhalation Technique in Children with Cystic Fibrosis
by: Argyri Petrocheilou, et al.
Published: (2020-09-01)

Cystic Fibrosis Treatment: A Paradigm for New Pediatric Medicines, Globalization of Drug Development and the Role of the European Medicines Agency
by: Klaus Rose, et al.
Published: (2015-03-01)

Clinical perspective on aztreonam lysine for inhalation in patients with cystic fibrosis
by: Martha K Daddario, et al.
Published: (2010-10-01)

Experience of the use of tobramycin for inhalation in children with cystic fibrosis
by: A. V. Orlov, et al.
Published: (2012-02-01)

Inhaled therapy in cystic fibrosis: agents, devices and regimens
by: Penny Agent, et al.
Published: (2015-06-01)

Adherence to tobramycin inhaled powder vs inhaled solution in patients with cystic fibrosis: analysis of US insurance claims data
by: Hamed K, et al.
Published: (2017-04-01)

Eradication of in cystic fibrosis patients with inhalation of dry powder tobramycin
by: Anne M. Akkerman-Nijland, et al.
Published: (2020-02-01)

Systematic review of the dry powder inhalers colistimethate sodium and tobramycin in cystic fibrosis
by: Lesley Uttley, et al.
Published: (2013-12-01)

INHALATION ANTIBIOTICS ARE ESSENTIAL FOR THE CONTROL OF INFECTION IN CHILDREN WITH CYSTIC FIBROSIS
by: O.I. Simonova, et al.
Published: (2011-05-01)

Efficacy of inhaled ciprofloxacin in the management of non-cystic fibrosis bronchiectasis
by: Julie Ann Justo, et al.
Published: (2013-10-01)

Prerequisites for a dry powder inhaler for children with cystic fibrosis.
by: Anne J Lexmond, et al.
Published: (2017-01-01)

INHALATION ANTIBIOTICS ARE ESSENTIAL FOR THE CONTROL OF INFECTION IN CHILDREN WITH CYSTIC FIBROSIS
by: O.I. Simonova, et al.
Published: (2011-01-01)

Bacillus anthracis Protective Antigen Kinetics in Inhalation Spore-Challenged Untreated or Levofloxacin/ Raxibacumab-Treated New Zealand White Rabbits
by: Cecil Chen, et al.
Published: (2013-01-01)

Variants in the interleukin 8 gene and the response to inhaled bronchodilators in cystic fibrosis
by: Larissa Lazzarini Furlan, et al.
Published: (2017-11-01)

Variants in the interleukin 8 gene and the response to inhaled bronchodilators in cystic fibrosis,
by: Larissa Lazzarini Furlan, et al.

Variants in the interleukin 8 gene and the response to inhaled bronchodilators in cystic fibrosis
by: Larissa Lazzarini Furlan, et al.
Published: (2017-11-01)

Cystic Fibrosis: Recent Insights into Inhaled Antibiotic Treatment and Future Perspectives
by: Giovanni Taccetti, et al.
Published: (2021-03-01)

Spotlight on inhaled ciprofloxacin and its potential in the treatment of non-cystic fibrosis bronchiectasis
by: Chorepsima S, et al.
Published: (2018-11-01)

Successes and Challenges: Inhaled Treatment Approaches Using Magnetic Nanoparticles in Cystic Fibrosis
by: Marsha Tan, et al.
Published: (2020-06-01)

The emergence of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis patients on inhaled antibiotics
by: Atqah AbdulWahab, et al.
Published: (2017-01-01)

Treatment satisfaction in cystic fibrosis: early patient experience with tobramycin inhalation powder
by: Greenberg J, et al.
Published: (2016-10-01)

Impaired cardiac and peripheral hemodynamic responses to inhaled β₂-agonist in cystic fibrosis
by: Van Iterson, E. H., et al.
Published: (2015)

Comparative in vitro activities of meropenem in combination with colistin, levofloxacin, or chloramphenicol against Achromobacter xylosoxidans strains isolated from patients with cystic fibrosis
by: Damla Damar-Çelik, et al.
Published: (2020-09-01)

Tobramycin Inhalation Powder (TIP): An Efficient Treatment Strategy for the Management of Chronic Infection in Cystic Fibrosis
by: John Lam, et al.
Published: (2013-01-01)

Clinical significance of lung microbiota and efficiency of the inhaled antibacterial therapy of cystic fibrosis in children
by: E. V. Pavlinova, et al.
Published: (2019-03-01)

Cystic fibrosis swine fail to secrete airway surface liquid in response to inhalation of pathogens
by: Xiaojie Luan, et al.
Published: (2017-10-01)

Inhaled antibiotics therapy for stable non-cystic fibrosis bronchiectasis: a meta-analysis
by: Meng-Jiao Xu, et al.
Published: (2020-06-01)

New highly effective dry powder tobramycin formulations for inhalation in the treatment of cystic fibrosis
by: Pilcer, Gabrielle
Published: (2008)

Inhaled tobramycin solution-associated recurrent eosinophilia and severe persistent bronchospasm in a patient with cystic fibrosis: a case report
by: Anbar Ran D, et al.
Published: (2007-03-01)

Transmission of rhinovirus in the Utah BIG-LoVE families: Consequences of age and household structure.
by: Frederick R Adler, et al.
Published: (2018-01-01)

A Case of Listeria monocytogenes Bacteremia Treated with Levofloxacin
by: Ferit ÇELİK, et al.
Published: (2014-12-01)

Personalised medicine for cystic fibrosis: treating the basic defect
by: J. Stuart Elborn
Published: (2013-03-01)

State of progress in treating cystic fibrosis respiratory disease
by: Flume Patrick A, et al.
Published: (2012-08-01)